Arceo, Erwin D.
HRN: 22-51-95 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2023
CEFUROXIME 1.5GM (VIAL)
02/03/2023
02/10/2023
IV
1.5g
Q8h
Post OR
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes